Home Investment Jivi, an AI-powered healthcare platform, has secured an undisclosed amount in a...

Jivi, an AI-powered healthcare platform, has secured an undisclosed amount in a strategic investment from Andrew Ng’s AI Fund.

0

Jivi, an AI-powered healthcare platform, has secured an undisclosed amount in a strategic investment from Andrew Ng’s AI Fund, marking the fund’s entry into the Indian market. Jivi, founded by Ankur Jain, former Chief Product Officer at BharatPe, combines artificial intelligence with medical expertise to offer advanced diagnostic and healthcare solutions.

Launched earlier this year, Jivi is designed to streamline patient journeys by integrating AI-driven diagnostics with doctor validation. The platform helps guide patients from diagnosis to treatment and preventive care, delivering instant, accurate health insights. Utilizing an advanced agentic architecture, Jivi provides patients with personalized health reports, detailing symptoms, potential diseases, and tailored treatment options. The platform currently supports over 20 healthcare specialties.

In just three months, Jivi has forged partnerships with over 100 doctors, physicians, and hospitals across India. This growing network strengthens its ability to deliver high-quality healthcare services to a broad audience.

The AI Fund, led by prominent computer scientist Andrew Ng, has a history of investing in innovative AI-based startups like Podcastle and Octagon AI. Supported by global investors such as Sequoia Capital and SoftBank Group, the AI Fund’s investment in Jivi represents a strategic move into India’s burgeoning healthcare market, emphasizing the growing role of AI in the sector.

Jivi’s mission to improve accessibility and accuracy in healthcare aligns with global trends of using AI to revolutionize diagnostics, offering patients quicker, more precise answers to health-related questions. With the backing of the AI Fund, the startup is poised for rapid expansion and innovation in the Indian healthcare landscape.

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Exit mobile version